Genus plc (LON:GNS - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,801.25 ($23.19) and traded as high as GBX 1,914 ($24.64). Genus shares last traded at GBX 1,901.92 ($24.49), with a volume of 5,376,931 shares traded.
Analyst Upgrades and Downgrades
Separately, Shore Capital reiterated a "buy" rating on shares of Genus in a report on Wednesday, December 11th.
Check Out Our Latest Analysis on GNS
Genus Trading Down 0.2 %
The company has a market capitalization of £1.24 billion, a PE ratio of 157.33, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The business has a fifty day moving average price of GBX 1,751.27 and a 200 day moving average price of GBX 1,803.75.
Genus (LON:GNS - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.51) EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. Analysts expect that Genus plc will post 70.9644323 EPS for the current fiscal year.
Insider Buying and Selling
In other Genus news, insider Jorgen Kokke sold 19,967 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of GBX 1,731 ($22.29), for a total value of £345,628.77 ($444,996.49). 0.75% of the stock is owned by corporate insiders.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
